As part of their original, long-term plan, David Barkay, founder and currently President and CEO and Edna Chosack, founder and currently Vice President of Strategic marketing are leaving the company to pursue new entrepreneurial challenges. Assuming the Simbionix presidency will be company Co-founder Ran Bronstein.Barkay, Bronstein and Chosack started Simbionix in 1997. Mr. Barkay and Ms. Chosack, along with their son, will relocate to Montreal to begin their new endeavors. Prior to joining the company, Bronstein was R&D manager of Kidum Multimedia Ltd., where he was responsible for the development of computer games. Earlier, he worked as projects manager at Tecnomatix Ltd. dealing with 3D graphics and robotic simulation.
“I look forward to this excellent opportunity to assist in taking our company to the next level,” stated Bronstein. “My previous focus has been on the development of our technology and I am now being offered an opportunity to assume more responsibility.”
“We will dearly miss David and Edna,” added Simbionix Chairman Avshalom Horan. “They have made an enormous difference in creating the great momentum we are presently experiencing in the marketplace.”
“With a $8 million revenue run rate and profitable operations, I felt it was the right time to move on and let the team grow,” said Barkay. “It’s been gratifying to see Simbionix move from the start-up stage and into sales, but it’s been particularly good to see the increased acceptance of simulation training in the medical community.”
Dr. Yael Friedman who has worked closely with Ms. Chosack as a Simbionix employee since 2002, will assume her responsibilities. “Dr. Friedman is a great asset for the company and provides a very deep competency in the development of meaningful medical content. She is supporting one of the best R&D teams in the industry,” said Chosack.